semaglutide injections denver GLP-1 for Medical Weight Loss in Semaglutide: Injection Home Kit –

The STEP clinical trial program demonstrated that patients receiving weekly subcutaneous semaglutide achieved average weight loss of 1018% of body weight over 68 weeks, compared to 23% with placebo

Your dermatologist will create a session plan suited to your individual needs

[1] The FDA has issued safety communications regarding compounded semaglutide products, which have been associated with adverse events including overdose due to improper compounding practices and dosing errors

Published on January 10th, 2026

There is no FDA-approved patch for a GLP-1, says Natasha Bhuyan, MD, a board-certified family physician at Amazon One Medical in Phoenix